Perimenopause and metabolic change

Something real is happening, and it is not just age

Women arriving in their forties and early fifties frequently report the same cluster: weight settling around the middle that was never there before, sleep breaking up, energy gone, and a sense that what used to work no longer does.

This is routinely attributed to ageing, to stress, or to not trying hard enough. The measurements suggest the transition itself contributes something independent of those.

What the longitudinal studies found

The best evidence comes from studies that followed the same women through the transition rather than comparing different women at different ages — SWAN, the Study of Women's Health Across the Nation, being the largest.

• Fat redistributes towards the abdomen, and visceral fat specifically increases across the transition — a change associated with the menopause transition over and above chronological ageing.
• Lean mass declines, which lowers resting energy expenditure. Some of the weight change is a muscle change rather than a fat change.
• Lipids shift unfavourably, with LDL and total cholesterol rising around the final menstrual period in a way that looks tied to the transition rather than to age alone.

Total weight gain across these years is often modest. The distribution change is the substantial part, which is why clothes stop fitting while the scale moves little — and why a clinic measuring only weight will tell a woman nothing is wrong.

Why the symptoms are so easy to misattribute

Hot flushes and night sweats fragment sleep. Fragmented sleep worsens insulin sensitivity, raises appetite and lowers daytime activity. Lower activity accelerates muscle loss. Each of these makes the next more likely, and none of them is visible as a single cause.

Mood changes in this period are also real and under‑recognised, with risk of depressive symptoms higher during the transition than before it. Presenting that as a metabolic problem, or as a reason for a weight‑loss medicine, is a category error.

The testing question

Hormone levels are of limited use here, which is covered in more depth elsewhere on this site. In perimenopause they swing erratically; a single oestradiol or FSH value may be normal one week and not the next, and guidelines advise against using them to diagnose the transition in women over 45.

What is worth measuring is the metabolic picture, because that is what changes and what can be acted on: glucose, HbA1c, a lipid panel, liver enzymes, thyroid function, and a full blood count. A seven‑marker baseline answers more useful questions here than a hormone panel does.

Thyroid deserves particular mention. Thyroid disease is more common in women, becomes more common with age, and produces almost exactly this symptom set. Missing it and attributing everything to menopause is a common and avoidable error.

What the evidence supports

Honestly, with its limits:

• Resistance training addresses the muscle loss directly, and the muscle loss is a large part of the metabolic change. The evidence for it in this group is reasonably strong and it is the most underprescribed intervention here.
• Protein intake adequate to support that training.
• Treating the sleep disruption, whatever its cause, because so much else follows from it.
• Hormone therapy is effective for vasomotor symptoms. Its effects on body composition and metabolic markers are more modest and more mixed, and it is not a weight‑loss treatment. Any clinic presenting it as one has moved past the evidence.

What is not known well enough

Whether treating the transition hormonally alters long‑term metabolic outcomes is not settled. Nor is the question of timing — the hypothesis that starting hormone therapy earlier produces different cardiovascular effects than starting later is plausible, debated, and not resolved.

Most of the longitudinal data also comes from North American and European cohorts. How precisely it transfers to a Costa Rican population is not something we can answer from what we have read.

The boundary

If this describes your past two years, the useful first step is measurement rather than a theory — and a clinician who will consider thyroid, sleep and mood before concluding it is simply menopause. What to do about it is a conversation, and a longer one than a blood test.